(Q51393515)

English

Evaluation of asymmetric dimethylarginine, nitric oxide levels and associated independent variables in obese and lean patients with polycystic ovarian syndrome.

scientific article published on 9 August 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20695761

Evaluation of asymmetric dimethylarginine, nitric oxide levels and associated independent variables in obese and lean patients with polycystic ovarian syndrome. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20695761

author name string

Ilgin Türkçüoğlu

1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20695761

Yaprak Engin-Üstün

2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20695761

Fahri Turan

3

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20695761

Zercan Kali

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20695761

Aysun Bay Karabulut

5

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20695761

Mutlu Meydanli

6

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20695761

Ayşe Kafkasli

7

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20695761

publication date

9 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20695761

Gynecological Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20695761

27

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20695761

9

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20695761

609-614

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20695761

The prevalence and features of the polycystic ovary syndrome in an unselected population

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

The effects of ovulation induction with gonadotrophins on the ovary and uterus and implications for assisted reproduction

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Insulin resistance and adolescent girls with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Nitric oxide and atherosclerosis

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Asymmetric dimethylarginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome and their relationship to metabolic parameters

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Oxidative stress markers in young patients with polycystic ovary syndrome, the relationship between insulin resistances

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Polymorphisms of the endothelial nitric oxide synthase gene in premenopausal women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Oxidised low-density lipoprotein concentration - early marker of an altered lipid metabolism in young women with PCOS.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.507291

21 January 2018

Identifiers

10.3109/09513590.2010.507291

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20695761

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20695761

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51393515&oldid=1232081380"